Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Computer program helps doctors diagnose lung cancer

29.11.2004


CAD software helps distinguish benign, malignant nodules seen on CT scans

Not all masses are cancer. When a person undergoes a scan to identify a lump or nodule, the radiologist looks at the texture, the borders and the shape to determine if it is malignant or just a benign growth.

Researchers at the University of Michigan Comprehensive Cancer Center are developing computer-aided diagnosis (CAD) methods to make that assessment easier. A computer program reads the same scans the radiologist views, and the combined judgment of the computer and radiologist helps detect more cancers, the researchers found.



"Our system is designed to help the radiologist. From our experiences in evaluating CAD for breast cancer, using computer aids significantly improves the performance of the radiologist in predicting malignancies of the masses. Radiologists with computers are able to detect more cancers than radiologists by themselves. We expect that CAD for lung cancer can achieve similar results," says Lubomir Hadjiyski, Ph.D., research assistant professor of Radiology at the U-M Medical School. Hadjiyski will present results of the study Sunday, Nov. 28, at the Radiological Society of North America’s annual meeting in Chicago.

In the study, researchers looked at 41 CT scans that showed nodules in the lungs. Current scans and previous scans were fed through a computer program specially designed by the U-M researchers to evaluate the size, texture, density and change over time of the nodules. Based on that information, the computer determines how likely the nodule is cancerous.

Previous attempts at computer-aided diagnosis have the computer analyze only the current scan. By allowing the computer to read and compare a series of scans, it gets a complete picture and has the same information the radiologist has.

A CAD system is designed to provide a second opinion to radiologists. The computer analyzes the images with computer-vision techniques specially designed for a given type of cancer or disease. At the same time, the radiologist examines the images and evaluates the likelihood of cancer. The radiologist then compares the two results and makes a final decision.

In many cases, the computer and the radiologist might come to the same conclusion. In other cases, though, the computer may determine a low rate of malignancy for a patient where the radiologist is on the fence. This could tip the scale against performing a biopsy. And if there’s a big difference between the radiologist’s judgment and the computer’s, the patient can be called back for a second look.

"The radiologist is not perfect and the computer is not perfect, but working together they detect more cancers," says Hadjiyski says.

Hadjiyski and his team have developed a similar program to detect breast cancer, and initial testing there is promising. The computer program for both lung and breast cancer needs FDA approval before it can be offered clinically. Hadjiyski stresses that computers will never replace the radiologist entirely but that the technology is meant to complement the radiologist’s judgment.

The one flaw with the computer-aided system is it may return false positive results, identifying masses as cancerous when they are benign. Hadjiyski notes, though, that overall the system detects more cancers. As the researchers fine-tune the technology, they hope to see fewer false positives, and may actually help radiologists identify benign lesions and reduce the number of people undergoing biopsies. Researchers hope next to develop a system that will both detect a lesion and identify it as malignant or benign.

In addition to Hadjiyski, researchers were Berkman Sahiner, Ph.D., associate professor of Radiology; Heang-Ping Chan, Ph.D., professor of Radiology; Naama Bogot, M.D., clinical lecturer in Radiology; Philip Cascade, M.D., professor of Cardiology and Radiology; and Ella Kazerooni, M.D., professor of Radiology.

Nicole Fawcett | EurekAlert!
Further information:
http://www.umich.edu

More articles from Health and Medicine:

nachricht Study suggests possible new target for treating and preventing Alzheimer's
02.12.2016 | Oregon Health & Science University

nachricht The first analysis of Ewing's sarcoma methyloma opens doors to new treatments
01.12.2016 | IDIBELL-Bellvitge Biomedical Research Institute

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

IHP presents the fastest silicon-based transistor in the world

05.12.2016 | Power and Electrical Engineering

InLight study: insights into chemical processes using light

05.12.2016 | Materials Sciences

High-precision magnetic field sensing

05.12.2016 | Power and Electrical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>